Abstract

Background Renal cell carcinoma is one of the most common malignant tumors in urinary system, seriously affecting people's health and life. This study aimed to evaluate the clinical value of multi-mode color Doppler flow imaging for diagnosis of solid renal tumor. Methods Sixty-six renal solid tumors from 63 patients were examined by color Doppler flow imaging (CDFI), power Doppler flow imaging (PDFI), superb microvascular imaging (SMI), and contrast-enhanced ultrasound (CEUS) before surgery. The diagnostic efficacy of the four methods was compared by determining blood flow grade and ring-like blood flow with Adler's method. Chi-square test and Fisher's test were performed to compare the results of sensitivity and specificity among four methods. Results Statistically significant differences in blood flow grade and ring-like blood flow were observed between benign and malignant renal tumors as detected by SMI and CEUS (P < 0.05), whereas no difference was found as detected by CDFI and PDFI (P > 0.05). The results indicated that the sensitivity and specificity of SMI (82.46%, 88.89%) and CEUS (84.21%, 88.89%) were higher than those of CDFI (42.11%, 66.67%) and PDFI (47.37%, 77.78%). Compared with the abilities of CDFI and PDFI, SMI and CEUS can better display the micro-blood flow in the tumors and evaluate the blood flow grading, which indicated that SMI and CEUS may have high values in the differential diagnosis of benign and malignant solid renal tumors. Conclusion SMI and CEUS can improve the sensitivity and specificity of the diagnosis of benign and malignant renal tumors and have a high application value.

Highlights

  • Renal cell carcinoma is one of the most common malignant tumors in urinary system, seriously affecting people’s health and life. is study aimed to evaluate the clinical value of multi-mode color Doppler flow imaging for diagnosis of solid renal tumor

  • Previous studies have shown that microvessel density is related to the grade, metastasis, and prognosis of tumors [19, 20]. erefore, it is of great significance to explore better methods to evaluate the microvascular system in renal parenchymal tumors for the early diagnosis and differential diagnosis of Renal cell carcinoma (RCC)

  • Adler method was used to classify the blood flow of solid tumors. ere was no significant difference between the blood flow classification of benign and malignant tumors as detected by color Doppler flow imaging (CDFI) and Power Doppler flow imaging (PDFI), whereas there was significant difference as detected by Superb microvascular imaging (SMI) and contrast-enhanced ultrasound (CEUS)

Read more

Summary

Introduction

Renal cell carcinoma is one of the most common malignant tumors in urinary system, seriously affecting people’s health and life. is study aimed to evaluate the clinical value of multi-mode color Doppler flow imaging for diagnosis of solid renal tumor. Sixty-six renal solid tumors from 63 patients were examined by color Doppler flow imaging (CDFI), power Doppler flow imaging (PDFI), superb microvascular imaging (SMI), and contrast-enhanced ultrasound (CEUS) before surgery. Significant differences in blood flow grade and ring-like blood flow were observed between benign and malignant renal tumors as detected by SMI and CEUS (P < 0.05), whereas no difference was found as detected by CDFI and PDFI (P > 0.05). Compared with the abilities of CDFI and PDFI, SMI and CEUS can better display the micro-blood flow in the tumors and evaluate the blood flow grading, which indicated that SMI and CEUS may have high values in the differential diagnosis of benign and malignant solid renal tumors. SMI and CEUS can improve the sensitivity and specificity of the diagnosis of benign and malignant renal tumors and have a high application value. SMI has been reported to be accurate and efficient in diagnosing breast tumors and liver lesions [10, 11]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call